This document summarises the main outcomes of the Guidelines Development Group (GDG) meeting held in Geneva, Switzerland, from 9 to 11 November 2015 to advise the World Health Organization Global TB Programme (WHO/GTB) on the revision of the policies on drug-resistant tuberculosis treatment. This 2016 ...

Resistance to tuberculosis (TB) drugs is a formidable obstacle to effective TB care and prevention globally. Multidrug-resistant TB (MDR-TB) is multifactorial and fuelled by improper treatment of patients, poor management of supply and quality of drugs, and airborne transmission of bacteria in public places. Case ...

Потребители инъекционных наркотиков (ПИН) подвержены повышенному риску инфицирования и развития туберкулеза (ТБ), независимо от их ВИЧ-статуса; ТБ является одной из ведущих причин ВИЧ-ассоциированной смертности среди ПИН. ПИН также существенно чаще инфицируются ВИЧ, гепатитом В и гепатитом С. Профилактика, диагностика и лечение ТБ, ВИЧ и вирусного гепатита ...

Настоящее сводное руководство содержит новые рекомендации по диагностике инфекции, вызываемой вирусом иммунодефицита человека (ВИЧ), оказанию помощи людям, живущим с ВИЧ, и использованию антиретровирусных (АРВ) препаратов для лечения и профилактики ВИЧ-инфекции. Эти рекомендации касаются всех этапов оказания помощи при ВИЧ-инфекции, включая тестирование, уход и лечение. В ...

Новое сводное руководство по вопросам профилактики, диагностики, лечения и ухода в связи с ВИЧ-инфекцией для ключевых групп населения объединяет все существующие руководящие указания Всемирной организации здравоохранения (ВОЗ), относящиеся к следующим пяти группам населения, которые имеют ключевое значение для действий по борьбе с ВИЧ. Эти группы следующие: ...

WHO guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection provide a public health approach for scaling up HIV care and treatment programmes and focus on simplified, harmonized and effective antiretroviral therapy (ART) regimens for use in resource-limited settings. In ...

In 2013, WHO released new treatment recommendations that expand the number of people eligible for treatment. The groups newly eligible for treatment include the following: all HIV-infected pregnant women, HIV-infected adults with hepatitis B infection and severe liver disease, serodiscordant couples, adults with CD4þ T-cell ...

People who inject drugs (PWID) are at increased risk of tuberculosis (TB). HIV further increases the risk of developing TB, with TB being a leading cause of mortality among PWID who live with HIV. Much of the evidence relates to TB among PWID; however, people ...

The 2013 ‘Consolidated guidelines on the use of antiretroviral (ARV) drugs for treating and preventing HIV infection’, released in July 2013, are the latest and most comprehensive of a series of important guidelines on antiretroviral therapy (ART) over the last decade from the World Health ...

With this update of the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection, WHO, for the first time, recommends that all people living with HIV be provided with antiretroviral therapy (ART). This will bring us one step closer to ...

The second edition of the World Health Organization (WHO) consolidated guidelines on the use of antiretrovirals (ARVs) updates the 2013 edition following an extensive review of evidence undertaken in 2015. Experience from country programmes, consultations with communities and modelling of potential impact have informed the ...

These consolidated guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the care of people living with HIV and the use of antiretroviral (ARV) drugs for treating and preventing HIV infection. They are structured along the continuum of HIV testing, care and ...

Objective: The objective was to evaluate community and healthcare worker (HCW) values and preferences on key topics to inform the development of the 2013 WHO consolidated guidelines for antiretroviral therapy in low and middle income countries. Design: Cross-sectional e-survey and e-forum discussion; focus group discussions (FGDs) Methods: ...

In June 2013, the WHO released consolidated guidelines on the use of antiretrovirals (ARVs) . The launch of these new guidelines is another milestone in the global endeavor toward universal access to antiretroviral treatment (ART) using the public health approach, pursuing the dual advantage of ...

By the end of 2012, the number of people receiving antiretroviral treatment (ART) in low and middle-income countries reached 9.7 million, including 7.2 million in sub-Saharan Africa. The bad news is that these figures represent only 65% of the global target of 15 million people ...

Objective: To determine the status of key national policies on the use of antiretroviral therapy (ART) at the time of the launch of the 2013 WHO consolidated guidelines as well as to track early progress towards adoption of these recommendations following dissemination. Design: Descriptive analysis of ...

Mental Health Gap Action Programme (mhGAP) – background About four out of five people in low- and middle-income countries who need services for mental, neurological and substance use conditions do not receive them. Even when available, the interventions often are neither evidence-based nor of high quality. ...